NYSE:UNH - UnitedHealth Group Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$250.29 -6.69 (-2.60 %)
(As of 07/17/2018 04:00 PM ET)
Previous Close$256.98
Today's Range$246.27 - $252.52
52-Week Range$183.86 - $259.01
Volume6.93 million shs
Average Volume3.35 million shs
Market Capitalization$248.61 billion
P/E Ratio24.86
Dividend Yield1.39%
UnitedHealth Group logoUnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals through programs offered by employers, payers, government entities, and directly with the care delivery systems. The OptumInsight segment offers software and information products, advisory consulting arrangements, and services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery and specialty pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.

Receive UNH News and Ratings via Email

Sign-up to receive the latest news and ratings for UNH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care


Debt-to-Equity Ratio0.56
Current Ratio0.71
Quick Ratio0.71


Trailing P/E Ratio24.86
Forward P/E Ratio19.83
P/E Growth1.56

Sales & Book Value

Annual Sales$201.16 billion
Price / Sales1.20
Cash Flow$12.15 per share
Price / Cash20.60
Book Value$51.42 per share
Price / Book4.87


EPS (Most Recent Fiscal Year)$10.07
Net Income$10.56 billion
Net Margins5.41%
Return on Equity22.06%
Return on Assets7.41%


Outstanding Shares960,980,000
Market Cap$248,605.80

The Truth About Cryptocurrencies

UnitedHealth Group (NYSE:UNH) Frequently Asked Questions

What is UnitedHealth Group's stock symbol?

UnitedHealth Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "UNH."

How often does UnitedHealth Group pay dividends? What is the dividend yield for UnitedHealth Group?

UnitedHealth Group declared a quarterly dividend on Wednesday, June 6th. Stockholders of record on Monday, June 18th will be given a dividend of $0.90 per share on Tuesday, June 26th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.44%. The ex-dividend date of this dividend is Friday, June 15th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $0.75. View UnitedHealth Group's Dividend History.

How will UnitedHealth Group's stock buyback program work?

UnitedHealth Group declared that its Board of Directors has initiated a stock buyback plan on Wednesday, June 6th 2018, which allows the company to buyback 100,000,000 outstanding shares, according to EventVestor. This buyback authorization allows the company to repurchase shares of its stock through open market purchases. Shares buyback plans are generally an indication that the company's board believes its shares are undervalued.

How were UnitedHealth Group's earnings last quarter?

UnitedHealth Group Inc (NYSE:UNH) posted its earnings results on Tuesday, July, 17th. The healthcare conglomerate reported $3.14 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $3.04 by $0.10. The healthcare conglomerate earned $56.09 billion during the quarter, compared to analysts' expectations of $56.10 billion. UnitedHealth Group had a net margin of 5.41% and a return on equity of 22.06%. The firm's revenue was up 12.1% compared to the same quarter last year. During the same period in the previous year, the business earned $2.46 EPS. View UnitedHealth Group's Earnings History.

When is UnitedHealth Group's next earnings date?

UnitedHealth Group is scheduled to release their next quarterly earnings announcement on Tuesday, July, 17th 2018. View Earnings Estimates for UnitedHealth Group.

What guidance has UnitedHealth Group issued on next quarter's earnings?

UnitedHealth Group updated its FY18 earnings guidance on Tuesday, July, 17th. The company provided EPS guidance of $12.50-12.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $12.63.

What price target have analysts set for UNH?

24 brokers have issued 1-year price objectives for UnitedHealth Group's stock. Their forecasts range from $213.00 to $300.00. On average, they expect UnitedHealth Group's stock price to reach $263.0435 in the next twelve months. This suggests a possible upside of 5.1% from the stock's current price. View Analyst Ratings for UnitedHealth Group.

What is the consensus analysts' recommendation for UnitedHealth Group?

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for UnitedHealth Group in the last year. There are currently 24 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

What are Wall Street analysts saying about UnitedHealth Group stock?

Here are some recent quotes from research analysts about UnitedHealth Group stock:
  • 1. According to Zacks Investment Research, "Shares of UnitedHealth Group have outperformed the industry year to date. The company's robust Government business and continued strong performance at Optum are driving long-term growth. Its international business and strong capital position driving business investment are the other positives. The company has been witnessing an increase in membership over the past many years. It again lifted its 2018 earnings guidance, buoying optimism among investors in the stock. The company has witnessed its 2018 estimate increase by 1.2% to $12.62 over the past 90 days. However, membership loss in its fee-based commercial as well as Brazilian businesses will contract the overall membership growth for UnitedHealth Group. Additionally, higher medical care ratio raises concern." (7/15/2018)
  • 2. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating on UNH shares and our price target remains at $300 (representing about 21% upside from current levels). The company kicks off 2Q18 reporting season on Tuesday, July 17. Overall, we expect the company to report strong results, continuing the trend from 1Q18. 1Q18 results were driven by strong growth in Medicare and Medicaid. We assume just marginal growth in commercial membership from 1Q18 levels. Indeed, Optum remains an important growth driver for the company, both as a standalone business unit as well as enabling the performance of the company’s captive (UHC) health plans." (7/5/2018)

Who are some of UnitedHealth Group's key competitors?

Who are UnitedHealth Group's key executives?

UnitedHealth Group's management team includes the folowing people:
  • Mr. Stephen J. Hemsley, Exec. Chairman (Age 65)
  • Mr. David Scott Wichmann, CEO & Director (Age 55)
  • Mr. John F. Rex, Exec. VP & CFO (Age 56)
  • Ms. Marianne D. Short, Exec. VP & Chief Legal Officer (Age 66)
  • Mr. Larry Chester Renfro, Vice Chairman & CEO of Optum (Age 64)

Has UnitedHealth Group been receiving favorable news coverage?

News stories about UNH stock have trended positive this week, according to Accern. Accern identifies positive and negative media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. UnitedHealth Group earned a news sentiment score of 0.32 on Accern's scale. They also assigned headlines about the healthcare conglomerate an impact score of 45.75 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future.

Who are UnitedHealth Group's major shareholders?

UnitedHealth Group's stock is owned by many different of institutional and retail investors. Top institutional investors include Bank of Montreal Can (0.16%), NN Investment Partners Holdings N.V. (0.16%), Swedbank (0.15%), Retirement Systems of Alabama (0.08%), Handelsbanken Fonder AB (0.06%) and Calamos Advisors LLC (0.06%). Company insiders that own UnitedHealth Group stock include D Ellen Wilson, Gail R Wilensky, Kenneth Irwin Shine, Larry C Renfro, Michele J Hooper, Richard T Burke, Steven H Nelson, Thomas E Roos and William C Ballard Jr. View Institutional Ownership Trends for UnitedHealth Group.

Which institutional investors are selling UnitedHealth Group stock?

UNH stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., Meag Munich Ergo Kapitalanlagegesellschaft MBH, Handelsbanken Fonder AB, Retirement Systems of Alabama, Bremer Trust National Association, Xact Kapitalforvaltning AB, Riverbridge Partners LLC and Cullinan Associates Inc.. Company insiders that have sold UnitedHealth Group company stock in the last year include Gail R Wilensky, Kenneth Irwin Shine, Larry C Renfro, Michele J Hooper, Richard T Burke, Steven H Nelson, Thomas E Roos and William C Ballard Jr. View Insider Buying and Selling for UnitedHealth Group.

Which institutional investors are buying UnitedHealth Group stock?

UNH stock was bought by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Calamos Advisors LLC, Gateway Investment Advisers LLC, DnB Asset Management AS, LGT Capital Partners LTD., Addenda Capital Inc., Calamos Wealth Management LLC and Stillwater Capital Advisors LLC. View Insider Buying and Selling for UnitedHealth Group.

How do I buy shares of UnitedHealth Group?

Shares of UNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is UnitedHealth Group's stock price today?

One share of UNH stock can currently be purchased for approximately $250.29.

How big of a company is UnitedHealth Group?

UnitedHealth Group has a market capitalization of $248.61 billion and generates $201.16 billion in revenue each year. The healthcare conglomerate earns $10.56 billion in net income (profit) each year or $10.07 on an earnings per share basis. UnitedHealth Group employs 260,000 workers across the globe.

How can I contact UnitedHealth Group?

UnitedHealth Group's mailing address is 9900 BREN ROAD EAST, MINNEAPOLIS MN, 55343. The healthcare conglomerate can be reached via phone at 952-936-1300 or via email at [email protected]

MarketBeat Community Rating for UnitedHealth Group (NYSE UNH)

Community Ranking:  3.6 out of 5 (star star star)
Outperform Votes:  1,169 (Vote Outperform)
Underperform Votes:  437 (Vote Underperform)
Total Votes:  1,606
MarketBeat's community ratings are surveys of what our community members think about UnitedHealth Group and other stocks. Vote "Outperform" if you believe UNH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UNH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.